ConductScience.org, home

Paper39655194

Myriad factors and pathways influencing tumor radiotherapy resistance.

Mi L and 1 other. Open Life Sci, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Myriad factors and pathways influencing tumor radiotherapy resistance. Papers, record 39655194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39655194

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myriad factors and pathways influencing tumor radiotherapy resistance.
PubMed
Journal
Open Life Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.49, provisional
iCite
Revised in PubMed
2024-12-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mi LLanjuan
2Zhang HHongquan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References237

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136316397Dynamic alternative DNA structures in biology and disease.Nat Rev Genet2023https://conductscience.org/library/papers/36316397PubMed
233597271Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.Clin Cancer Res2021https://conductscience.org/library/papers/33597271PubMed
326993419To live or let die: Unclear task of autophagy in the radiosensitization battle.Radiother Oncol2016https://conductscience.org/library/papers/26993419PubMed
428134023Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications.Int J Radiat Biol2017https://conductscience.org/library/papers/28134023PubMed
529658569β‑catenin nuclear translocation induced by HIF‑1α overexpression leads to the radioresistance of prostate cancer.Int J Oncol2018https://conductscience.org/library/papers/29658569PubMed
636333630NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.Apoptosis2023https://conductscience.org/library/papers/36333630PubMed
734508258The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34508258PubMed
831276435SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.Autophagy2019https://conductscience.org/library/papers/31276435PubMed
922258607The DNA damage response and cancer therapy.Nature2012https://conductscience.org/library/papers/22258607PubMed
1025615283Experimental phase diagram of negatively supercoiled DNA measured by magnetic tweezers and fluorescence.Nanoscale2015https://conductscience.org/library/papers/25615283PubMed
1126122185Opportunities and challenges of radiotherapy for treating cancer.Nat Rev Clin Oncol2015https://conductscience.org/library/papers/26122185PubMed
1237423560Co-targeting autophagy and NRF2 signaling triggers mitochondrial superoxide to sensitize oral cancer stem cells for cisplatin-induced apoptosis.Free Radic Biol Med2023https://conductscience.org/library/papers/37423560PubMed
1322770212Cancer epigenetics: from mechanism to therapy.Cell2012https://conductscience.org/library/papers/22770212PubMed
1425033211Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues.PLoS One2014https://conductscience.org/library/papers/25033211PubMed
1532459988Biomarker-Guided Development of DNA Repair Inhibitors.Mol Cell2020https://conductscience.org/library/papers/32459988PubMed
1633945288Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma.J Clin Oncol2021https://conductscience.org/library/papers/33945288PubMed
1728619042Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.BMC Cancer2017https://conductscience.org/library/papers/28619042PubMed
1836522816
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Ann Oncol2023https://conductscience.org/library/papers/36522816PubMed
1930465162Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.Cancer Metastasis Rev2018https://conductscience.org/library/papers/30465162PubMed
2028302823PARP inhibitors: Synthetic lethality in the clinic.Science2017https://conductscience.org/library/papers/28302823PubMed

See all 237 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42935534Definitive radiotherapy versus surgery after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score-matched study of efficacy and safety.Front Oncol2026https://conductscience.org/library/papers/42935534PubMed
42749398mRNA-based therapeutics in lung Cancer: Mechanisms, applications, and translational challenges.J Genet Eng Biotechnol2026https://conductscience.org/library/papers/42749398PubMed
42465745Tumor-associated macrophages: potential therapeutic strategies and future prospects in radioresistance of cancer.Front Immunol2026https://conductscience.org/library/papers/42465745PubMed
41726230Ferroptosis and immunity: rewiring the tumor microenvironment for therapy.RSC Adv2026https://conductscience.org/library/papers/41726230PubMed
41656818[Mechanistic research progress on radiotherapy resistance of cancer stem cells].Zhong Nan Da Xue Xue Bao Yi Xue Ban2025https://conductscience.org/library/papers/41656818PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39655194

GET https://conductscience.org/api/papers/v1/39655194/references?page=2